September 8, 2022

Descartes Announces Fiscal 2023 Second Quarter Financial Results

Record Revenues and Income from Operations WATERLOO, Ontario, Sept. 07, 2022 (GLOBE NEWSWIRE) — The Descartes Systems Group Inc. (TSX:DSG) (Nasdaq:DSGX) announced its financial results for its fiscal 2023 second quarter (Q2FY23). All financial results referenced are in United States (US) currency and, unless otherwise indicated, are determined in accordance with US Generally Accepted Accounting […]

Read More

AGC Biologics and Evax Partner to Advance Promising Equine Allergy Vaccine Candidate

The CDMO supports clinical stages using its Heidelberg site’s microbial-based biologics services Seattle, Sept. 07, 2022 (GLOBE NEWSWIRE) — AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), today announced a new partnership with Evax, a developer of equine vaccines to treat chronic diseases, respiratory disorders and allergies. Through this partnership, Evax […]

Read More

Recent Posts